Significant Loss of Areal Bone Mineral Density Following Prolonged Bed Rest During Treatment With Teriparatide.

Martin, Christopher T; Niewoehner, Catherine B; Burmeister, Lynn A

Martin, Christopher T; Niewoehner, Catherine B; Burmeister, Lynn A.

Afiliación

Martin CT; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, University of Minnesota Twin Cities, Minneapolis, Minnesota 55455.
Niewoehner CB; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, University of Minnesota Twin Cities, Minneapolis, Minnesota 55455.
Burmeister LA; Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, University of Minnesota Twin Cities, Minneapolis, Minnesota 55455.

J Endocr Soc ; 1(6): 609-614, 2017 Jun 01.

Article en En | MEDLINE | ID: mdl-29264514

RESUMEN

We present of a case of severe osteoporosis with thoracic myelopathy secondary to nontraumatic T8 compression fracture managed nonsurgically with 3.5 months of bed rest. Despite treatment with teriparatide starting at initial presentation, 1-year follow-up dual energy x-ray absorptiometry scan revealed a significantly greater than expected 19% reduction in lumbar spine bone mineral density (BMD) and a 6% reduction in total hip density. Daily alcohol consumption, severe osteoporosis at baseline, and immobilization secondary to transient myelopathy treated with strict bed rest all likely contributed to unexpected BMD findings.

Palabras clave

bone mineral density; immobilization; osteoporosis; teriparatide

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Endocr Soc Año: 2017 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google